Literature DB >> 23072745

PHLPP1 gene deletion protects the brain from ischemic injury.

Bo Chen1, Jessica A Van Winkle, Patrick D Lyden, Joan H Brown, Nicole H Purcell.   

Abstract

A recently discovered protein phosphatase PHLPP (PH domain Leucine-rich repeat Protein Phosphatase) has been shown to dephosphorylate Akt on its hydrophobic motif (Ser473) thereby decreasing Akt kinase activity. We generated PHLPP1 knockout (KO) mice and used them to explore the ability of enhanced in vivo Akt signaling to protect the brain against ischemic insult. Brains from KO mice subjected to middle cerebral artery occlusion (MCAO) for 2 hours showed significantly greater increases in Akt activity and less neurovascular damage after reperfusion than wild-type (WT) mice. Remarkably, infarct volume in the PHLPP1 KO was significantly reduced compared with WT (12.7±2.7% versus 22.9±3.1%) and this was prevented by Akt inhibition. Astrocytes from KO mice and neurons in which PHLPP1 was downregulated showed enhanced Akt activation and diminished cell death in response to oxygen-glucose deprivation. Thus, deletion of PHLPP1 can enhance Akt activation in neurons and astrocytes, and can significantly increase cell survival and diminish infarct size after MCAO. Inhibition of PHLPP could be a therapeutic approach to minimize damage after focal ischemia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23072745      PMCID: PMC3564187          DOI: 10.1038/jcbfm.2012.150

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  39 in total

Review 1.  Activating Akt and the brain's resources to drive cellular survival and prevent inflammatory injury.

Authors:  Z Z Chong; F Li; K Maiese
Journal:  Histol Histopathol       Date:  2005-01       Impact factor: 2.303

2.  PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth.

Authors:  Tianyan Gao; Frank Furnari; Alexandra C Newton
Journal:  Mol Cell       Date:  2005-04-01       Impact factor: 17.970

3.  Mechanism of activation of protein kinase B by insulin and IGF-1.

Authors:  D R Alessi; M Andjelkovic; B Caudwell; P Cron; N Morrice; P Cohen; B A Hemmings
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

4.  Phospholipase Cepsilon is a nexus for Rho and Rap-mediated G protein-coupled receptor-induced astrocyte proliferation.

Authors:  Simona Citro; Sundeep Malik; Emily A Oestreich; Julie Radeff-Huang; Grant G Kelley; Alan V Smrcka; Joan Heller Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-18       Impact factor: 11.205

5.  The role of Akt signaling in oxidative stress mediates NF-kappaB activation in mild transient focal cerebral ischemia.

Authors:  Yun Seon Song; Purnima Narasimhan; Gab Seok Kim; Joo Eun Jung; Eun-Hee Park; Pak H Chan
Journal:  J Cereb Blood Flow Metab       Date:  2008-07-16       Impact factor: 6.200

6.  Severe blood-brain barrier disruption and surrounding tissue injury.

Authors:  Bo Chen; Beth Friedman; Qun Cheng; Phil Tsai; Erica Schim; David Kleinfeld; Patrick D Lyden
Journal:  Stroke       Date:  2009-11-05       Impact factor: 7.914

7.  Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo.

Authors:  Nicole H Purcell; Benjamin J Wilkins; Allen York; Marc K Saba-El-Leil; Sylvain Meloche; Jeffrey Robbins; Jeffery D Molkentin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-20       Impact factor: 11.205

8.  The neurovascular unit in health and disease: introduction.

Authors:  Eng H Lo; Gary A Rosenberg
Journal:  Stroke       Date:  2008-12-08       Impact factor: 7.914

Review 9.  Middle cerebral artery occlusion model in rodents: methods and potential pitfalls.

Authors:  Fudong Liu; Louise D McCullough
Journal:  J Biomed Biotechnol       Date:  2011-01-23

10.  The endogenous inhibitor of Akt, CTMP, is critical to ischemia-induced neuronal death.

Authors:  Takahiro Miyawaki; Dimitry Ofengeim; Kyung-Min Noh; Adrianna Latuszek-Barrantes; Brian A Hemmings; Antonia Follenzi; R Suzanne Zukin
Journal:  Nat Neurosci       Date:  2009-04-06       Impact factor: 24.884

View more
  17 in total

Review 1.  Calpain-1 and Calpain-2: The Yin and Yang of Synaptic Plasticity and Neurodegeneration.

Authors:  Michel Baudry; Xiaoning Bi
Journal:  Trends Neurosci       Date:  2016-02-10       Impact factor: 13.837

2.  Pharmacological inhibition of pleckstrin homology domain leucine-rich repeat protein phosphatase is neuroprotective: differential effects on astrocytes.

Authors:  Travis C Jackson; Jonathan D Verrier; Tomas Drabek; Keri Janesko-Feldman; Delbert G Gillespie; Thomas Uray; Cameron Dezfulian; Robert S Clark; Hülya Bayir; Edwin K Jackson; Patrick M Kochanek
Journal:  J Pharmacol Exp Ther       Date:  2013-09-10       Impact factor: 4.030

Review 3.  Turning off AKT: PHLPP as a drug target.

Authors:  Alexandra C Newton; Lloyd C Trotman
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014       Impact factor: 13.820

4.  PH domain leucine-rich repeat protein phosphatase 2 (PHLPP2) regulates G-protein-coupled receptor kinase 5 (GRK5)-induced cardiac hypertrophy in vitro.

Authors:  Szu-Tsen Yeh; Cristina M Zambrano; Walter J Koch; Nicole H Purcell
Journal:  J Biol Chem       Date:  2018-04-08       Impact factor: 5.157

5.  Physiological activation of Akt by PHLPP1 deletion protects against pathological hypertrophy.

Authors:  Courtney Moc; Amy E Taylor; Gino P Chesini; Cristina M Zambrano; Melissa S Barlow; Xiaoxue Zhang; Åsa B Gustafsson; Nicole H Purcell
Journal:  Cardiovasc Res       Date:  2014-11-19       Impact factor: 10.787

6.  Distinct roles for μ-calpain and m-calpain in synaptic NMDAR-mediated neuroprotection and extrasynaptic NMDAR-mediated neurodegeneration.

Authors:  Yubin Wang; Victor Briz; Athar Chishti; Xiaoning Bi; Michel Baudry
Journal:  J Neurosci       Date:  2013-11-27       Impact factor: 6.167

7.  Regeneration in the nervous system with erythropoietin.

Authors:  Kenneth Maiese
Journal:  Front Biosci (Landmark Ed)       Date:  2016-01

8.  Pleckstrin homology (PH) domain and Leucine Rich Repeat Phosphatase 1 (Phlpp1) Suppresses Parathyroid Hormone Receptor 1 (Pth1r) Expression and Signaling During Bone Growth.

Authors:  Samantha R Weaver; Earnest L Taylor; Elizabeth L Zars; Katherine M Arnold; Elizabeth W Bradley; Jennifer J Westendorf
Journal:  J Bone Miner Res       Date:  2021-02-08       Impact factor: 6.741

9.  Detection of PHLPP1α/β in human and mouse brain by different anti-PHLPP1 antibodies.

Authors:  Travis C Jackson; Hülya Bayir; Milos D Ikonomovic; Keri Janesko-Feldman; Zaichuan Mi; Tianyan Gao; Edwin K Jackson; Patrick M Kochanek
Journal:  Sci Rep       Date:  2015-04-01       Impact factor: 4.379

Review 10.  On the PHLPPside: Emerging roles of PHLPP phosphatases in the heart.

Authors:  Kellie A Lemoine; Julianna M Fassas; Shirag H Ohannesian; Nicole H Purcell
Journal:  Cell Signal       Date:  2021-07-25       Impact factor: 4.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.